diabetes News
-
Showcase
VisionQuest Abstract on Diabetic Peripheral Neuropathy Accepted by ADA
We’re looking forward to presenting “Detecting Diabetic Peripheral Neuropathy Utilizing Thermoregulation of the Plantar Foot” at the upcoming 82nd Scientific Sessions of the American Diabetes Association. Our research aims to detect thermal (infrared) biomarkers of diabetic peripheral neuropathy on the feet of diabetic subjects who have not been diagnosed with DPN. By analyzing ...
-
The European Association for the Study of Diabetes celebrates in IFEMA MADRID its 60th Annual Meeting
The annual meeting of the European Association for the Study of Diabetes expects to maintain for its 60th edition the participation level of previous years, in which around 15,000 diabetologists and diabetes experts from 130 countries attended. The scientific programme will feature more than 1,200 sessions on the latest results in diabetes research by leading experts in the field. The congress ...
-
Defymed at the International Conference on Advanced Technologies and Treatments of Diabetes (ATTD)
Our CEO, COO and BDO (Severine, Richard and Manuel) will attend the International Conference on Advanced Technologies and Treatments of Diabetes (ATTD) which will take place in Barcelona (Spain) from April 27th to 30th. The purpose of the ATTD meeting is to highlight innovative technologies in diabetes treatment. It brings together developers of new technologies, like us, with the diabetes ...
By Defymed
-
Medis QFR continues to show superiority over standard angiography, after a FU-period of 2 years
In the September 2022 issue of JACC journals (https://www.jacc.org/doi/10.1016/j.jacc.2022.06.044), the FAVOR III China Study Group published a sub-study that was aimed to ascertain whether the beneficial outcomes of QFR® guidance for lesion selection during PCI is affected by diabetes status. From the total of 3825 patients enrolled, 1295 (33.9%) had diabetes. The study confirmed that the ...
-
Georgia`s cyclists are pedaling hard to stop diabetes at local tour de cure event
Morgan Kendrick, President of Blue Cross and Blue Shield of Georgia, Appointed as Tour de Cure Executive Sponsor. In an effort to reduce the growing prevalence of diabetes, Blue Cross and Blue Shield of Georgia (BCBSGa), is the premiere sponsor of the Atlanta Tour de Cure® (TDC) on Sunday, May 15, 2011 at Bouckaert Farm in Fairburn, Georgia. This multi-faceted ride is the American Diabetes ...
-
CeQur Acquires Assets from Calibra Medical, Inc.
CeQur today announced that the company has acquired select assets of Calibra Medical, Inc., one of the Johnson & Johnson Diabetes Care Companies. The transaction includes an exclusive worldwide license for the wearable, on-demand insulin delivery system previously known as OneTouch Via™. The Calibra system enables people with diabetes to discreetly and conveniently deliver rapid-acting ...
-
LifeScan is Proud to be a Founding Supporter of The Diabetes Way Website
LifeScan, a world leader in blood glucose monitoring and digital health technology, is committed to supporting resources that help promote diabetes education and improved health management, including our most recent sponsorship of The Diabetes Way website, offering a straight-forward educational resource – even for those questions you were afraid to ask. Along with educational content ...
By LifeScan
-
New training manual for treatment of type 1 diabetes in children in developing countries
In collaboration with the International Society for Pediatric and Adolescent Diabetes (ISPAD) Novo Nordisk has today launched a training manual specific to the diagnosis and treatment of diabetes care for children in developing countries. Unveiled on the opening day of the ISPAD Congress 'ISPAD 2010', which is currently taking place in Buenos Aires, this first edition of the manual is available ...
-
Epinex Diagnostics Enters Digital Health Field - Launches `Am I Diabetic` Mobile Phone App
Epinex Diagnostics, Inc., a Tustin, California USA based biomedical company, commemorates National Diabetes Month by launching the “Am I Diabetic” mobile phone app for iPhone and Android devices. The function of this app is to provide educational information and awareness about diabetes. With over half a billion people around the world suffering from diabetes and millions more at ...
-
Selected: American Diabetes Association HealthTech Showcase, Nov. 2020
Nodexus was selected as an invited exhibitor at the American Diabetes Association HealthTech Showcase in November ...
By Nodexus Inc.
-
DEFYMED at SFD congress in Nice (France)
Several people of the team (Severine, Karine and Manuel) are really happy to participate to the annual congress of the French society of diabetes (SFD) which will take place in Nice (South of France) from March 22nd to 25th. The team will be in the start-up booth E02 to present our latest news but also a unique chance for you to take in hands our ExOlin® device which is the latest innovation ...
By Defymed
-
Huateng Pharma Introduces Anti-Diabetes Intermediates
Huateng Pharma proudly announces the launch of a groundbreaking suite of anti-diabetes intermediates, featuring key compounds such as Canagliflozin, Dapagliflozin, Empagliflozin, and Semaglutide. Emphasizing the potential impact on diabetes drug development, Huateng Pharma's Research and Development Director expressed enthusiasm, stating, "Our new line of anti-diabetes intermediates represents a ...
-
I heard elderly people with diabetes are more likely to break bones
Walking in a crowd, six out of ten elderly people are at risk for diabetes. Nowadays, diabetes has become the most common disease among the elderly. Studies have shown that women with diabetes have an increased risk of fractures. In men, however, the relationship between diabetes and fracture risk is unclear. For a time, the grandfathers in the diabetes specialized hospital, start road, were ...
-
African health leaders gather to address significant rise in diabetes
With the incidence of diabetes rising at an alarming rate worldwide, UN member states have resolved to host a summit in 2011 on this growing healthcare threat. In preparation for this, South Africa hosted the Diabetes Leadership Forum Africa 2010 (DLFA) in Johannesburg on 30 September and 1 October. The forum, which was co-hosted by the South African Ministry of Health and the World Diabetes ...
-
“High Treatment Satisfaction with 3-day Insulin Patch is Independent of Patient Demographics: A Post-Hoc Analysis” — a presentation at the American Diabetes Association 80th Scientific Sessions
Progression of Type 2 Diabetes Treatment Due to natural progression of type 2 diabetes, maintenance of glycemic targets requires a stepwise approach to treatment in order to achieve and maintain glycemic control and avoid complications1'2 Comprehensive lifestyle modifications combined with metformin Addition of up to 3 oral medications or GLP-1 RA injection Addition of basal (long-acting) ...
-
“Detecting Diabetic Peripheral Neuropathy Utilizing Thermoregulation Biomarkers of the Plantar Foot” Poster Presentation
VisionQuest founder and CEO Peter Soliz (PhD) presented the poster “Detecting diabetic peripheral neuropathy utilizing thermoregulation biomarkers of the plantar foot” at the American Diabetes Association’s 82nd Scientific Sessions last Sunday in New Orleans. “I was so glad to be able to meet with colleagues and make new connections in person after not traveling for over ...
-
CeQur Appoints Rick Doubleday and Dr. Meret Gaugler to Board of Directors
CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today announced the appointments of Rick Doubleday and Meret Gaugler, Ph.D., to its Board of Directors. ...
-
Novo Nordisk praises historic declaration to fight diabetes
On December 13, 2010, twenty-two countries from the Middle East and Northern Africa (MENA) and five international organisations agreed on the "Dubai Declaration on Diabetes and Chronic Non-Communicable Diseases in the Middle East and Northern Africa Region." The agreement was the culmination of the Novo Nordisk sponsored MENA Diabetes Leadership Forum held on December 12-13 in Dubai. "We are ...
-
Defymed at ATTD 2023
22-25 February (Berlin, Germany): Defymed at the Advanced Technologies and treatments for Diabetes. The purpose of the ATTD meeting is to highlight innovative technologies and treatments in diabetes management. It brings together developers of new technologies with the diabetes professionals and caretakers, researchers, industries, startup companies, investors, reimbursement authorities and ...
By Defymed
-
Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market
Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced a "reverse split" of its shares of common stock at a ratio of 1-for-3. The Company's common stock will begin ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you